LivaNova (LIVN) Competitors

$62.41
-0.71 (-1.12%)
(As of 05/8/2024 ET)

LIVN vs. ITGR, TMDX, CNMD, HAE, SLNO, INMD, BLFS, AXGN, OM, and MASI

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Integer (ITGR), TransMedics Group (TMDX), CONMED (CNMD), Haemonetics (HAE), Soleno Therapeutics (SLNO), InMode (INMD), BioLife Solutions (BLFS), AxoGen (AXGN), Outset Medical (OM), and Masimo (MASI). These companies are all part of the "medical" sector.

LivaNova vs.

Integer (NYSE:ITGR) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, community ranking, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

Integer has a net margin of 6.01% compared to Integer's net margin of -2.68%. Integer's return on equity of 13.59% beat LivaNova's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.01% 11.25% 5.69%
LivaNova -2.68%13.59%7.06%

Integer has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500.

99.3% of Integer shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 2.0% of Integer shares are held by company insiders. Comparatively, 0.2% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, LivaNova had 5 more articles in the media than Integer. MarketBeat recorded 13 mentions for LivaNova and 8 mentions for Integer. LivaNova's average media sentiment score of 0.98 beat Integer's score of 0.59 indicating that Integer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
5 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Integer has higher revenue and earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.63B2.32$90.65M$2.8939.15
LivaNova$1.15B2.93$17.55M-$0.60-104.02

Integer currently has a consensus target price of $120.50, indicating a potential upside of 6.51%. LivaNova has a consensus target price of $66.20, indicating a potential upside of 6.07%. Given LivaNova's stronger consensus rating and higher possible upside, equities research analysts clearly believe Integer is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
LivaNova
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

LivaNova received 5 more outperform votes than Integer when rated by MarketBeat users. Likewise, 68.78% of users gave LivaNova an outperform vote while only 63.39% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
IntegerOutperform Votes
374
63.39%
Underperform Votes
216
36.61%
LivaNovaOutperform Votes
379
68.78%
Underperform Votes
172
31.22%

Summary

Integer beats LivaNova on 12 of the 18 factors compared between the two stocks.

Get LivaNova News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$3.38B$3.22B$5.01B$7.78B
Dividend YieldN/A1.68%2.87%3.96%
P/E Ratio-104.029.87174.6819.25
Price / Sales2.9360.222,407.6679.98
Price / Cash14.9066.1234.0328.62
Price / Book2.633.974.954.39
Net Income$17.55M$87.99M$105.41M$217.65M
7 Day Performance-0.81%1.68%0.38%1.04%
1 Month Performance11.77%-7.02%-3.63%-2.66%
1 Year Performance33.53%0.84%3.34%9.46%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
1.729 of 5 stars
$109.92
+0.1%
$120.50
+9.6%
+40.0%$3.68B$1.60B38.0310,500
TMDX
TransMedics Group
1.7296 of 5 stars
$124.44
+5.8%
$119.00
-4.4%
+79.3%$4.07B$241.62M-366.00584Insider Selling
CNMD
CONMED
4.986 of 5 stars
$70.20
+2.7%
$107.86
+53.6%
-43.5%$2.16B$1.24B26.904,000Analyst Forecast
Insider Buying
Positive News
HAE
Haemonetics
4.1511 of 5 stars
$93.39
+1.4%
$104.67
+12.1%
+14.0%$4.68B$1.27B37.963,034Insider Selling
News Coverage
SLNO
Soleno Therapeutics
3.5939 of 5 stars
$49.23
+3.6%
$55.60
+12.9%
+1,001.4%$1.64BN/A-16.5833Upcoming Earnings
INMD
InMode
3.6117 of 5 stars
$17.36
+0.7%
$32.80
+88.9%
-47.7%$1.46B$492.05M7.55581
BLFS
BioLife Solutions
2.2697 of 5 stars
$18.16
+3.9%
$23.40
+28.9%
-6.4%$822.65M$143.27M-11.95409
AXGN
AxoGen
2.4341 of 5 stars
$5.88
-10.4%
$10.67
+81.4%
-39.2%$257.02M$159.01M-11.31426Analyst Downgrade
OM
Outset Medical
1.086 of 5 stars
$3.00
+5.3%
$5.42
+80.6%
-79.4%$155.10M$130.38M-0.86480News Coverage
Gap Down
MASI
Masimo
4.6175 of 5 stars
$136.25
+1.7%
$137.43
+0.9%
-36.1%$7.09B$2.05B90.235,200Earnings Report
Analyst Forecast
News Coverage
Gap Down

Related Companies and Tools

This page (NASDAQ:LIVN) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners